Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Explore credit cards that offer the best rewards for gas purchases. Keep your fuel costs down while earning rewards.
27,882 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Nike has fallen sharply from its peak, but a blue-chip brand can still offer compelling upside. This guide analyzes t...
Bitcoin has entered a stark profit-and-loss juncture, with a growing share of the supply losing money as prices hover...
The NANC ETF, built to mirror congressional disclosure trades, is facing a tougher 2026 as interest rates move higher...
Nvidia sits at the center of AI, and May 20 earnings looms large. This guide breaks down whether you should Nvidia st...
Two of Washington’s most watched political figures disclosed stakes in Vistra, a mid-size energy player poised as AI ...
Retail investors are retreating from crypto while institutions step up exposure, reshaping liquidity and risk. The sh...
Buffett’s approach hinges on durable moats and proven profitability. Here are two warren buffett wide-moat stocks to ...
A high-ranking Google DeepMind AI executive leaves for OpenAI, triggering investor chatter about Alphabet stock and t...
Chip stocks rise on liquidity-driven rotations, but Morgan Stanley’s CIO cautions this may be near peak rather than a...
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
President Trump signals possible new tariffs during the February State of the Union, renewing a policy debate that co...